Leerink Partnrs Has Strong Estimate for TVTX FY2026 Earnings
Analysts at Leerink Partnrs raised their FY2026 EPS estimates for shares of Travere Therapeutics in a research note issued to investors on Tuesday, February 11th. Leerink Partnrs analyst J. Schwartz ...
Leerink Partnrs Analysts Raise Earnings Estimates for Waters
Research analysts at Leerink Partnrs upped their Q3 2025 EPS estimates for shares of Waters in a note issued to investors on ...
Elanco stock touches 52-week low at $11.11 amid market challenges
Incorporated (NYSE: ELAN) shares have reached a 52-week low, dipping to $11.11, as the company faces a tumultuous market environment. With a market capitalization of $5.55 billion and a beta of 1.42, ...